Shots: The termination is based on results from P-IIb study, assessing Novexatin vs PBO, which was unable to meet a main goal of study under FDA guidelines with no superiority […]readmore
Tags : License
Shots: Novartis to get royalty-free worldwide, intellectual property rights for CBMG’s CAR-T related technology. CBMG to get a mark-up on the manufacturing cost. CBMG will take care of the manufacturing […]readmore
Shots: St. Jude Children’s Research Hospital out-licenses exclusive worldwide rights for Lentiviral Gene Therapy for X-linked Severe Combined Immunodeficiency also known as “bubble boy” This therapy is presently being assessed […]readmore